Dexco Statistics
Total Valuation
Dexco has a market cap or net worth of BRL 6.37 billion. The enterprise value is 12.29 billion.
Market Cap | 6.37B |
Enterprise Value | 12.29B |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Dexco has 808.36 million shares outstanding. The number of shares has decreased by -0.76% in one year.
Shares Outstanding | 808.36M |
Shares Change (YoY) | -0.76% |
Shares Change (QoQ) | +0.30% |
Owned by Insiders (%) | 20.71% |
Owned by Institutions (%) | 26.43% |
Float | 306.18M |
Valuation Ratios
The trailing PE ratio is 11.79 and the forward PE ratio is 20.09. Dexco's PEG ratio is 2.27.
PE Ratio | 11.79 |
Forward PE | 20.09 |
PS Ratio | 0.83 |
PB Ratio | 0.97 |
P/FCF Ratio | 187.12 |
PEG Ratio | 2.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.29, with an EV/FCF ratio of 361.16.
EV / Earnings | 22.69 |
EV / Sales | 1.61 |
EV / EBITDA | 7.29 |
EV / EBIT | 22.91 |
EV / FCF | 361.16 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 119.71.
Current Ratio | 1.51 |
Quick Ratio | 1.08 |
Debt / Equity | 119.71 |
Debt / EBITDA | 5.04 |
Debt / FCF | 235.42 |
Interest Coverage | 0.57 |
Financial Efficiency
Return on equity (ROE) is 8.72% and return on invested capital (ROIC) is 1.99%.
Return on Equity (ROE) | 8.72% |
Return on Assets (ROA) | 1.59% |
Return on Capital (ROIC) | 1.99% |
Revenue Per Employee | 537,603 |
Profits Per Employee | 38,083 |
Employee Count | 14,228 |
Asset Turnover | 0.44 |
Inventory Turnover | 3.77 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.94% in the last 52 weeks. The beta is 0.90, so Dexco's price volatility has been similar to the market average.
Beta (5Y) | 0.90 |
52-Week Price Change | +1.94% |
50-Day Moving Average | 7.53 |
200-Day Moving Average | 7.54 |
Relative Strength Index (RSI) | 50.41 |
Average Volume (20 Days) | 3,313,810 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexco had revenue of BRL 7.65 billion and earned 541.84 million in profits. Earnings per share was 0.67.
Revenue | 7.65B |
Gross Profit | 1.80B |
Operating Income | 439.78M |
Pretax Income | 529.40M |
Net Income | 541.84M |
EBITDA | 1.52B |
EBIT | 439.78M |
Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 2.07 billion in cash and 8.01 billion in debt, giving a net cash position of -5.80 billion or -7.18 per share.
Cash & Cash Equivalents | 2.07B |
Total Debt | 8.01B |
Net Cash | -5.80B |
Net Cash Per Share | -7.18 |
Equity (Book Value) | 6.69B |
Book Value Per Share | 8.13 |
Working Capital | 1.80B |
Cash Flow
In the last 12 months, operating cash flow was 1.44 billion and capital expenditures -1.41 billion, giving a free cash flow of 34.04 million.
Operating Cash Flow | 1.44B |
Capital Expenditures | -1.41B |
Free Cash Flow | 34.04M |
FCF Per Share | 0.04 |
Margins
Gross margin is 23.57%, with operating and profit margins of 5.75% and 7.08%.
Gross Margin | 23.57% |
Operating Margin | 5.75% |
Pretax Margin | 6.92% |
Profit Margin | 7.08% |
EBITDA Margin | 19.86% |
EBIT Margin | 5.75% |
FCF Margin | 0.45% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 2.73%.
Dividend Per Share | 0.22 |
Dividend Yield | 2.73% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 0.01% |
Buyback Yield | 0.76% |
Shareholder Yield | 3.50% |
Earnings Yield | 8.48% |
FCF Yield | 0.53% |
Stock Splits
The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.
Last Split Date | Dec 21, 2022 |
Split Type | Forward |
Split Ratio | 1.1 |